Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 32 (MTND6P32) is a pseudogene sequence related to the MT-ND6 gene, which encodes a core subunit of mitochondrial complex I involved in electron transport and ATP synthesis[1][3]. As a pseudogene, MTND6P32 does not produce a functional protein and is not considered a therapeutic target. There may be confusion with the functional MT-ND6 gene, which is a bona fide gene important for mitochondrial function and implicated in certain hereditary diseases and mitochondrial disorders, but MTND6P32 itself is not studied for drug interactions, mechanisms, or disease roles[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 32 (MTND6P32).